253 / 460
N. Nakamura, H. Yoshikawa, K. Shino
252
[11] Knutsen G, Drogset JO, Engebretsen L,
Grøntvedt T, Isaksen V, Ludvigsen TC,
Roberts S, Solheim E, Strand T, Johansen O. A
randomized trial comparing autologous chondrocyte
implantation with microfracture. Findings at five years.
J
Bone Joint Surg Am. 2007 Oct;89(10): 2105-12.
[12] Saris DB, Vanlauwe J, Victor J, Haspl M,
Bohnsack M, Fortems Y, Vandekerckhove B,
Almqvist KF, Claes T, Handelberg F, Lagae K,
van der Bauwhede J, Vandenneucker H, Yang
KG, Jelic M, Verdonk R, Veulemans N,
Bellemans J, Luyten FP. Characterized chondrocyte
implantation results in better structural repair when treating
symptomatic cartilage defects of the knee in a randomized
controlled trial versus microfracture.
Am J Sports Med. 2008
Feb; 36(2): 235-46.
[13] Saris DB, Vanlauwe J, Victor J, Almqvist
KF, Verdonk R, Bellemans J, Luyten FP, TIG/
ACT/01/2000&EXT Study Group. Treatment of
symptomatic cartilage defects of the knee: characterized
chondrocyte implantation results in better clinical outcome
at 36 months in a randomized trial compared to microfracture.
Am J Sports Med. 2009 Nov; 37 Suppl 1:10S-19S.
[14] Vanlauwe J, Saris DB, Victor J, Almqvist
KF,BellemansJ,LuytenFP;TIG/ACT/01/2000&EXT
Study Group. Five-year outcome of characterized
chondrocyte implantation versus microfracture for
symptomatic cartilage defects of the knee: early treatment
matters.
Am J Sports Med. 2011 Dec;39(12):2566-74.
[15] Kon E, Gobbi A, Filardo G, Delcogliano M,
Zaffagnini S, Marcacci M. Arthroscopic Second-
GenerationAutologous Chondrocyte Implantation Compared
With Microfracture for Chondral Lesions of the Knee.
Prospective Nonrandomized Study at 5 Years.
Am J Sports
Med. 2009 Jan; 37(1): 33-41.
[16] Bartlett W, Skinner JA, Gooding CR,
Carrington RW, Flanagan AM, Briggs TW,
Bentley G. Autologous chondrocyte implantation versus
matrix-induced autologous chondrocyte implantation for
osteochondral defects of the knee: a prospective, randomised
study.
J Bone Joint Surg Br. 2005 May;87(5): 640-5.
[17] Gooding CR, Bartlett W, Bentley G,
Skinner JA, Carrington R, Flanagan A. A
prospective, randomised study comparing two techniques of
autologous chondrocyte implantation for osteochondral defects
in the knee: Periosteum covered versus type I/III collagen
covered.
Knee 2006 Jun; 13(3): 203-10. Epub 2006 Apr 27.
[18] Peterson L, Minas T, Brittberg M, Nilsson
A, Sjogren-Jansson E, Lindahl A. Two- to 9-year
outcome after autologous chondrocyte transplantation of the
knee.
Clin Orthop Relat Res. 2000 May;(374):212-34.
[19] Kreuz PC, Steinwachs M, Erggelet C,
Lahm A, Krause S, Ossendorf C, Meier D,
Ghanem N, Uhl M. Importance of sports in cartilage
regeneration after autologous chondrocyte implantation: a
prospective study with a 3-year follow-up.
Am J Sports Med.
2007 Aug; 35(8): 1261-8.
[20] Ebert JR, Robertson WB, Lloyd DG, Zheng
MH, Wood DJ, Ackland T. Traditional vs accelerated
approaches to post-operative rehabilitation following matrix-
induced autologous chondrocyte implantation (MACI):
comparison of clinical, biomechanical and radiographic
outcomes.
Osteoarthritis Cartilage. 2008 Oct; 16(10):1131-
40. Epub 2008 Apr 22.
[21] Wakitani S, Imoto K, Yamamoto T, Saito M,
Murata N, Yoneda M. Human autologous culture
expanded bone marrow mesenchymal cell transplantation
for repair of cartilage defects in osteoarthritic knees.
Osteoarthritis Cartilage. 2002 Mar; 10(3): 199-206.
[22] Nejadnik H, Hui JH, Feng Choong EP, Tai BC,
Lee EH. Autologous bone marrow-derived mesenchymal
stem cells versus autologous chondrocyte implantation: an
observational cohort study.
Am J Sports Med. 2010 Jun;
38(6): 1110-6.